Screener
Ironwood Pharmaceuticals IRWD Accrued Research And Development Expense Current
Accrued Research And Development Expense Current at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept irwd:AccruedResearchAndDevelopmentExpenseCurrent.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091987
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
| Current liabilities: | ||
| Accounts payable | $911 | $2,898 |
| Accrued research and development costs | 3,124 | 3,149 |
| Accrued expenses and other current liabilities | 25,534 | 33,239 |
| Current portion of operating lease liabilities | 3,285 | 3,252 |
| Current portion of convertible senior notes | — | 199,680 |
| Total current liabilities | 32,854 | 242,218 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ironwood Pharmaceuticals's accrued research and development expense current?
- Ironwood Pharmaceuticals (IRWD) reported accrued research and development expense current of $3.12M in Q2 2026.
- How has Ironwood Pharmaceuticals's accrued research and development expense current changed year-over-year?
- Ironwood Pharmaceuticals's accrued research and development expense current decreased by 31.4% year-over-year, from $4.55M to $3.12M.
- What is the long-term trend for Ironwood Pharmaceuticals's accrued research and development expense current?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's accrued research and development expense current has grown at a 10.7% compound annual growth rate (CAGR), from $1.9M to $3.15M.
- What does accrued research and development expense current mean?
- Accrued Research And Development Expense Current as reported by Ironwood Pharmaceuticals, Inc. - Class A.
Ask your AI about Ironwood Pharmaceuticals's accrued research and development expense current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude